Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Can-Fite Biopharma Ltd (CANF) vs Creative Medical Technology Holdings, Inc. (CELZ)

Can-Fite Biopharma Ltd and Creative Medical Technology Holdings, Inc. are both Biotechnology companies. Can-Fite Biopharma Ltd and Creative Medical Technology Holdings, Inc. are of similar size ($6.5M and $6.4M). Can-Fite Biopharma Ltd grew revenue faster over the last twelve months: −3.36% against −79.4%. Creative Medical Technology Holdings, Inc. has the higher net margin (0.00% vs −1,148.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Can-Fite Biopharma Ltd leads on 8 and Creative Medical Technology Holdings, Inc. on 6.

Valuation

Metric CANF CELZ Biotechnology median
P/E n/m n/m 7.88
P/S 12.74 222.10 11.47
P/B 2.03 0.44 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.38 0.74
EV/Sales 3.65 (136.42) 10.73
Earnings yield (596.58%) (202.94%) (28.84%)
Free cash flow yield (193.97%) (297.24%) (23.03%)

Profitability

Metric CANF CELZ Biotechnology median
Gross margin 0.00% 61.18% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin (1,148.62%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (77.91%) (57.72%)
Return on assets 0.00% (73.30%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CANF CELZ Biotechnology median
Revenue growth (TTM) (3.36%) (79.42%) 5.64%
EPS growth (last fiscal year) 45.23% 32.08% —
Revenue growth, 5-year CAGR (11.90%) (48.43%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CANF CELZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.60 12.91 4.73
Net debt to EBITDA 0.86 1.20 0.96

Dividend

Metric CANF CELZ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CANF CELZ Biotechnology median
Market cap 6.54m 6.36m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack